The expansion of Medicaid may drastically change the demographics of beneficiaries.
The expansion of Medicaid may drastically change the demographics of beneficiaries. With health reform, adults making up to 138% of the federal poverty level will be able to sign up for Medicaid under a federally paid expansion starting in 2014. This shift in regulations may result in a more diverse Medicaid population.
According to the recent study, which used statistics from the National Health and Nutrition Examination Survey, the new group of Medicaid beneficiaries are:
Study author Dr Tammy Chang says while the new Medicaid enrollees will be healthier and less obese or depressed than the current population, there will also more will be smokers and drinkers. She adds that the Medicaid population is usually stereotyped as high-risk and chronically ill—this can affect the way doctors and providers view treatment for these beneficiaries since the costs of those patients is often higher.
“It’s really a game changer,” said Dr Chang, “A lot of providers think of Medicaid as people who take a lot of time to see, who use a lot of resources.”
A shift in beneficiary demographics could also mean a greater focus on prevention and family care, rather than chronic disease. Sara Rosenbaum, a health law professor at the George Washington University School of Public Health, says the new information could give hesitant states the incentive they need to pursue Medicaid expansion. “It’s about the need for good family care, routine care,” she said. “One would hope that encourages states to open up their programs.”
Around the Web
How Expansion Will Change The Look Of Medicaid [NPR]
Law Will Shift Demographics For Medicaid Toward Healthier Group, Study Finds [Kaiser Health News]
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen